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Abstract: 
 
Background: Toxoplasmosis is a common worldwide infection caused by the protozoan 
Toxoplasma gondii. In Cameroon, several recent studies have reported high seroprevalence of this 
parasitosis in various hospitals (Douala, Limbe, Njinikom and Yaoundé). The aim of this study was 
to determine whether this high prevalence of toxoplasmosis might occur in other regions of the 
country. 
Methodology: Serological tests by the indirect Enzyme Linked Immunosorbent Assay (ELISA) for 
IgG and IgM were carried out on 200 pregnant women (36 HIV-positive and 164 HIV-negative) at 
the Protestant Hospital of Mbouo-Bandjoun in western Cameroon to determine the presence of 
Toxoplasma gondii infection and to identify the risk factors associated with seropositivity of the 
subjects. 
Results: The overall seroprevalence of anti-Toxoplasma antibodies was 45.5%. The prevalence 
rate was 80.5% in the HIV-positive group (47.2% IgG, 22.2% IgM and 11.1% IgG + IgM) and 
37.8% in the HIV-negative group (25.6%, 9.7% and 2.4% respectively). Using a multivariate 
logistic regression analysis, the secondary level of educational, presence of HIV infection, and 
frequency of close contacts with cats were significantly associated with the prevalence of IgG 
and/or IgM antibodies. 
Conclusion: Compared with previous reports of human toxoplasmosis in Cameroon, the 
prevalence in our study showed a decrease in the disease occurrence. Further studies are needed 
to determine whether this decrease is localised to our study or a general phenomenon currently 
affecting the country. 
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Résumé: 
 
Contexte: La toxoplasmose est une infection répandue dans le monde entier et causée par le 
protozoaire Toxoplasma gondii. Au Cameroun, plusieurs études récentes ont signalé une forte 
séroprévalence de la parasitose dans divers hôpitaux (Douala, Limbé, Njinikom et Yaoundé). Le but 
de cette étude était de déterminer si cette forte prévalence de la toxoplasmose pouvait se produire 
dans d'autres régions du pays. 
Méthodologie: Des tests sérologiques pour quantifier les IgG et IgM par dosage indirect immuno-
enzymatique indirect selon la méthode ELISA ont été effectués sur 200 femmes enceintes (36 VIH-
positives et 164 VIH-négatives) à l'hôpital protestant de Mbouo-Bandjoun, dans l'ouest du 
Cameroun, afin de déterminer la présence d'infectiona à T. gondii et d’identifier les facteurs de 
risque associés à la séropositivité des sujets. 
Résultats: La séroprévalence globale des anticorps anti-Toxoplasma était de 45,5 %. Le taux de 
prévalence était de 80,5 % dans le groupe VIH-positif (47,2 % IgG, 22,2 % IgM et 11,1 % IgG + 
IgM) et de 37,8 % dans le groupe VIH négatif (25,6 %, 9,7 % et 2,4 %, respectivement). L’emploi 
d’une analyse de régression logistique multivariée a montré que le niveau secondaire d'éducation, 
la présence d'une infection par le VIH et la fréquence des contacts étroits avec les chats étaient 
significativement associés à la prévalence des anticorps IgG et/ou IgM. 
Conclusion: Par rapport aux rapports précédents sur la toxoplasmose humaine au Cameroun, la 
prévalence dans notre étude a montré une diminution de la fréquence de la maladie. Des études 
complémentaires sont nécessaires pour déterminer si cette baisse est localisée dans notre étude ou 
est un phénomène général qui affecte actuellement le pays. 
 




Toxoplasmosis is a common world- 
wide infection caused by the protozoan 
Toxoplasma gondii. In immuno-
competent adults and children, this 
infection is usually asymptomatic or 
causes symptoms such as fever or 
malaise that spontaneously resolve           
(1, 2). Sometimes, it can induce foetal 
complications in pregnant women (2) 
and also cervical lymphadenopathy and/ 
or ocular disease in immuno-
compromised patients infected with the 
human immunodeficiency virus (HIV) 
(3). This parasitosis can be contracted 
by ingestion of tissue cysts in 
undercooked contaminated meat, poorly 
washed raw vegetables or in 
contaminated drinking water (4). Cats 
and other members of the family Felidae 
are reported as the single definitive 
hosts because they excrete resistant 
oocysts in their faeces. Other mammals, 
including humans, serve as intermediate 
hosts in which the parasite can cause 
systemic infection that leads to the 
formation of tissue cysts (4).    
Infection caused by T. gondii is 
considered a global zoonotic disease               
of public health importance. The 
distribution of this parasite depends on 
the countries and weather conditions 
where the oocysts survive in 
environment (4, 5). It is estimated that 
between 30% and 65% of all people in 
the world are infected with toxoplasma 
(6). Toxoplasmosis can be detected in 
these patients by the use of specific anti-
Toxoplasma IgG and IgM antibodies. IgM 
antibodies increased from day 5 after an 
acute infection to reach a maximum after 
1-2 months and then rapidly decreased 
to low or undetectable levels. In many 
cases, they persist for years after acute 
infection (7). IgG antibodies appeared 
later than IgM and are generally 
detectable within the first two weeks 
after infection. The peak levels of IgG 
occurred after a period ranging from 12 
weeks to 6 months (7).  
In Cameroon, several recent studies 
have reported high seroprevalence of 
toxoplasmosis in various hospitals.                
A prevalence of 69.9% (out of 133 men 
and women) was reported among HIV 




patients at Yaoundé (8). The same study 
reported a rate of 70% among 110 
pregnant women at Douala (9) within 
the same year. In the coastal region of 
Cameroon, a rate of 71.8% (out of 170 
pregnant women) was reported in the 
health district of Limbe (10). Values 
close to the rates reported above were 
also recorded in 2016; 54.5% (out of 
178 women of child-bearing age) at 
Njinikom, north-western region (11) and 
78.6% (out of 327 pregnant women) in 
Douala (12). All these studies emphasize 
the need to sensitize pregnant women to 
the disease and its mode of transmission 
during their prenatal follow-up, in order 
to reduce the risk of first infection during 
their pregnancy.    
 In view of the results from these 
studies, it becomes necessary to 
investigate whether this high prevalence 
of toxoplasmosis might occur in other 
regions of Cameroon with the following 
two research questions; (i) what is the 
prevalence of this parasitosis in 
mountainous area located at 2000m 
altitude such as Western Highlands?, and 
what are the risk factors associated with 
this disease?  
 
Materials and methods: 
 
Study population 
The study population consists of 
pregnant women attending the 
Protestant Hospital, Mbouo-Bandjoun 
(West Cameroon) for antenatal clinic and 
medical check-ups, enrolled by simple 
random sampling between June and 
September 2016. As about 20% of the 
women followed up in this hospital are 
HIV-positive (F. F. Djuikwo Teukeng, 
personal communication), patient enrol- 
ment was based on a sample size of 200 
subjects in order to have a significant 
number of HIV-positive women (n > 31). 
No exclusion criteria were used in the 
choice of pregnant women recruited             
into the study.    
 The subjects were from 
Bafoussam (n=103), Bandjoun (n=55) 
and 11 other municipalities located in the 
West region (n=19). Nineteen others 
from Douala (n=14) or Yaoundé (n=5) 
have also consulted in this hospital. The 
detection of T. gondii antibodies was 
carried out during the course of their 
first pregnancy for 40 of the subjects.  
 
Study protocol 
Each participant in this study 
completed a structured questionnaire. 
This questionnaire contained simple 
questions about known risk factors of T. 
gondii exposure in addition to clinical and 
socio-demographic information. Blood 
samples were collected from each 
participant into two pre-labelled tubes. 
The blood from the EDTA-containing 
tube was immediately tested for the 
presence of anti-HIV antibodies using 
test strips (Alere Determine™ HIV-1/2) 
according to the manufacturer's 
recommendations. The second blood 
sample was centrifuged at 3000 rpm for 
15 minutes to obtain the serum. The 
serum was stored at -20°C and then 
tested for the presence of T. gondii 
antibodies using the indirect Enzyme 
Linked Immunosorbent Assay (ELISA) 
method and anti-Toxoplasma IgG and 
IgM antibody ELISA kits (Golden Bio 
Technologies Corporation, Upland, Cali- 
fornia, USA).  
 
Ethical consideration 
Ethical clearance was obtained from 
the Evangelical University of Bandjoun 
(2016/0017) and authorization to collect 
and analyse blood samples was also 
given by the Protestant Hospital 
administrative authorities. All partici-
pants were informed of the study goals, 
procedures and finality, and all signed 
the informed consent form. Informed 
consent was provided for subjects less 
than 21 years by their parents or 
guardians. 
 
Sociodemographic and risk factors  
 Information about the main 
behavioural factors known for 
toxoplasmosis such as contact with cats 
and garden soil, consumption of 
undercooked and smoked meat sold 
along roads, raw unwashed vegetables 
and fruits, drinking unfiltered water, and 
hand washing practices (4), were 
collected into a structured questionnaire. 
Socio-demographic and clinical histories 
such as age, educational level, marital 
status, profession, place of residence, 
number of previous pregnancies, 




gestational age of present pregnancy, 
and HIV status were also collected. The 
professions of the subjects were 
classified according to the criteria 
defined by the National Institute of 
Statistics in Cameroon (13). 
 
Statistical analysis 
 The overall seroprevalence of 
toxoplasmosis took into account the 
different types of antibodies studied and 
was assessed using the ratio between 
the numbers of serologically positive 
anti-T. gondii samples and that of all 
samples. The same protocol was used to 
calculate the prevalence of infection for 
each antibody type (IgG, IgM or IgG + 
IgM). These prevalence rates were given 
with their 95% confidence intervals. The 
Pearson’s Chi square test was used to 
establish levels of significance between 
HIV-positive and HIV-negative groups. 
 Univariate logistic regression was 
first used to test whether potential risk 
factors were associated with the 
prevalence of infection. Variables with a 
p value less than 0.25 in univariate 
analysis were integrated into a 
multivariate logistic regression model to 
control the possible effect of confounding 
factors. The relative risk of infection was 
measured using odds ratios (OR) with 
95% confidence intervals. All analyses 





Seroprevalence of IgG & IgM antibodies 
 Of the 200 pregnant women 
involved in this study, 36 (18%) were 
HIV-infected while 164 (82%) were HIV-
negative (Table 1). The table shows the 
distribution of the pregnant women in 
relation to HIV infection and the 
presence of anti-Toxoplasma antibodies. 
Overall seroprevalence rate of T. gondii 
infection was 45.5% (91/200). In the 
HIV-positive group, 29 of 36 (80.5%) 
were seropositive for toxoplasmosis;      
17 (47.2%) for IgG, 7 (22.2%) for IgM 
and 4 (11.1%) for both antibody types. 
In the HIV-negative group, the sero- 
prevalence rate was 36.5% (62 of 164) 
with 25.0% (42 of 164) for IgG, 9.1% 
(16 of 164) for IgM and 2.4% (4 of 164) 
for both antibody types.  
  
Table 1: Seroprevalence of Toxoplasma gondii infections among pregnant women attending the Protestant 
Hospital, Mbouo-Bandjoun, Cameroon according to HIV status 
 
Number of pregnant 
women 
Population group: number of patients (prevalence in % (95% CI)) 
HIV-positive (n = 36) HIV-negative  (n = 164) Total (n = 200) 
Positive IgG                17 (47.22)             
(30.40-64.51) 
42 (25.61)               
(19.10-33.00) 
59 (29.50)              
(23.20-36.34) 
 
Positive IgM                8 (22.22)                
(10.10-39.15) 
16 (9.76)                
(5.67-15.36) 
24 (12.00)                
(7.84-17.33) 
 
Positive IgG + IgM 4 (11.11)                    
(3.11-26.06) 
       4 (2.44)      
(0.67-6.13) 
8 (4.00)                    
(1.74-7.73) 
 
Total of women with anti-
Toxoplasma antibodies 
29 (80.56)                 
(63.90-91.81) 
62 (37.80)              
(30.30-45.70) 
91 (45.50)               
(38.40-52.67) 
 n = number of women per group; CI = confidence interval   
 
 Table 2 shows significant differ- 
ences between the two groups of subjects. 
The number of women positive for IgG 
antibodies was significantly higher in the 
HIV-positive group than in HIV-negative 
patients (p<0.05), and the same was 
observed for IgM and both IgG and IgM 
antibodies. In each group considered 
separately (Table 2), the number of IgG-
positive women was significantly higher 
than those patients positive for IgM 
antibodies or both types of antibodies. 
 Fig 1 shows the distribution of the 
91 seropositive women through their 
pregnancy period in relation to the type 
of antibodies. Women with positive IgG 
antibodies were more in the second and 
third trimesters (25 and 21 subjects 
respectively, compared to 15 in the third 
trimester). The distribution of the 23 
women with positive IgM antibodies was 
roughly uniform during the three 
trimesters, and the same was noted for 
the 8 women with both types of 
antibodies. 
 




Table 2: Differences between groups of subjects or antibody types (Chi2 test) 
 
Difference between Parameter or group 
studied 
χ2 value p value 
HIV positive and HIV negative IgG+ 6.63 < 0.05 
IgM+ 5.33 < 0.05 
IgG+, IgM+ 5.78 < 0.05 
IgG+ and IgM+ HIV-positive 4.96 < 0.05 
HIV-negative 14.16 < 0.001 
IgG+ and IgG+, IgM+ HIV-positive 11.36 < 0.001 
HIV-negative 36.51 < 0.001 
IgM+ and IgG+, IgM+ HIV-positive 1.60 NS 
HIV-negative 7.66 < 0.01 





Fig 1: Distribution of 91 pregnant women infected with Toxoplasma gondii in relation to the antibody type: 
a = HIV-positive women; b = HIV-negative women  
  




Factors associated with Toxoplasma 
gondii seropositivity 
 As shown in Tables 3 and 4, 
educational status at secondary level, 
HIV infection, and close contacts with 
cats were identified as possible risk 
factors associated with T. gondii 
infection. A multiple logistic regression 
analysis (Table 5) showed that these 
three variables were significantly 
associated with the prevalence of IgG 
and IgM antibodies in the subjects. 
  
 Compared to women without HIV 
infection, the HIV-infected women were 
5.7 times more likely to develop 
Toxoplasma infection. Similarly, women 
with secondary level of education and 
those who had frequent close contacts 
with cats were, respectively 4.48 and 
2.95 times more likely to be infected 
with this parasite when compared to 
women with a primary level of education 




Table 3: Univariate logistic regressions of the socio-demographic and clinical characteristics of pregnant women 
attending the Protestant Hospital, Mbouo-Bandjoun (West Cameroon) 
Variable and group (total 
number of women per group) 





Age category    
 20-25 years (52) 46.15 (32.20 - 60.53)   
 26-30 years (82) 46.34 (35.20 - 57.70) 1.00 (0.50 - 2.03) 0.98 
 31-35 years (42) 45.24 (29.80 - 61.33) 0.96 (0.42 - 2.18) 0.92 
 ≥ 36 years (24) 41.67 (22.10 - 63.36) 0.83 (0.30 - 2.20) 0.71 
Level of education    
 Primary (56) 55.36 (41.40 - 68.66)   
 Secondary (68) 35.29 (24.00 - 47.83) 0.44 (0.21 - 0.90) 0.02 * 
 Higher (76) 47.37 (35.70 - 59.16) 0.72 (0.36 - 1.44) 0.36 
Marital status    
 Married (116) 47.41 (38.00 - 56.90)   
 Single (84) 42.86 (32.10 - 54.13) 0.83 (0.47 - 1.46) 0.52 
Occupation    
 Artisans (43) 51.16 (35.40 - 66.70)   
 Housewives (49) 46.94 (32.50 - 61.73) 0.84 (0.37 - 1.92) 0.69 
  Intermediate & 
higher professions (39) 
41.03 (25.50 - 57.90) 0.66 (0.27 - 1.59) 0.36 
 Others (69) 43.48 (31.50 - 55.96) 0.73 (0.34 - 1.58) 0.43 
Residence    
 Bafoussam (106) 48.11 (38.30 - 58.03)   
 Bandjoun (56) 48.21 (34.60 - 61.97) 1.00 (0.52 - 1.92) 0.99 
 Douala (14) 28.57 (8.38 - 58.10) 0.43 (0.11 - 1.38) 0.18 
 Other towns (24) 37.50 (18.70 - 59.41) 0.65 (0.25 - 1.58) 0.35 
Number of previous pregnancies   
 1 (41) 41.46 (26.30 - 57.89)   
 2 (41) 56.10 (39.70 - 71.53) 1.80 (0.76 - 4.39) 0.19 
 3 (44) 54.55 (38.80 - 69.61) 1.69 (0.72 - 4.05) 0.23 
 4 (35) 31.43 (16.80 - 49.29) 0.65 (0.25 - 1.65) 0.37 
 ≥ 5 (39) 41.03 (25.50 - 57.90) 0.98 (0.40 - 2.40) 0.97 
Miscarriages    
 No (135) 47.41 (38.70 - 56.18)   
 Yes (65) 41.54 (29.40 - 54.44) 0.78 (0.43 - 1.42) 0.43 
Gestational age (present pregnancy)   
Trimester 1 (55) 47.27 (33.60 - 61.20)   
Trimester 2 (83) 42.17 (31.40 - 53.51) 0.81 (0.41 - 1.62) 0.55 
Trimester 3 (62) 48.39 (35.40 - 61.44) 1.05 (0.51 - 2.17) 0.90 
Knowledge of toxoplasmosis   
 No (130) 46.92 (38.10 - 55.87)   
 Yes (70) 42.86 (31.00 - 55.25) 0.84 (0.47 - 1.52) 0.58 
HIV infection    
 No (164) 37.80 (30.80 - 45.70)   
 Yes (36) 80.56 (63.90 - 91.81) 6.81(2.96 - 17.76) 0.0001 *** 
* p < 0.05, ** p < 0.01, *** p < 0.001. CI = confidence interval 
 






Table 4: Univariate logistic regressions of behavioural risk factors of pregnant women attending the Protestant 
Hospital, Mbouo-Bandjoun (West Cameroon) 
Variable and group (total 
number of women per 
group) 





Presence of cats at home   
 No (147) 40.82 (32.70 - 49.22)   
 Yes (53) 58.49 (44.10 - 71.86) 2984,708 (0, NC) 0.98 
Close contact with cats   
 Never (96) 35.42 (25.90 - 45.84)   
 Rarely (39) 38.46 (23.30 - 55.38) 1.14 (0.52 - 2.45) 0.74 
 Often (65) 64.62 (51.70 - 76.08) 3.33 (1.74 - 6.51) 0.0003 *** 
Consumption of undercooked meat   
 Never (168) 44.64 (36.90 - 52.50)   
        Sometimes (32) 50.00 (31.00 - 68.11) 1.24 (0.58 - 2.66) 0.58 
Consumption of smoked meat sold along roads   
 Never (76) 38.16 (27.20 - 50.02)   
 Rarely (50) 46.00 (31.80 - 60.68) 1.38 (0.67 - 2.86) 0.38 
 Often (74) 52.70 (40.70 - 64.43) 1.81 (0.95 - 3.48) 0.07 
Consumption of raw and unwashed vegetables or fruit  
 Never (157) 45.22 (37.20 - 53.35)   
 Sometimes (43) 46.51 (31.10 - 62.35) 1.05 (0.53 - 2.07) 0.88 
Consumption of water   
 Forehole1 (18) 55.56 (30.70 - 78.47)   
 Source1 (27) 37.04 (19.40 - 57.63) 0.47 (0.14 - 1.57) 0.22 
            Mineral water (15) 46.67 (21.20 - 73.41) 0.70 (0.17 - 2.77) 0.61 
     Tap water (140) 45.71 (37.20 - 54.34) 0.67 (0.24 - 1.81) 0.43 
Hand washing   
 Always (158) 43.67 (35.80 - 51.78)   
 Sometimes (42) 52.38 (36.40 - 68.00) 1.42 (0.72 - 2.82) 0.31 
Contact with garden soil   
 No (9) 55.56 (21.20 - 86.30)   
 Yes (191) 45.03 (37.80 - 52.37) 0.66 (0.16 - 2.55) 0.53 





Table 5: Multivariate logistic regression with selected variables of pregnant women attending the Protestant 
Hospital, Mbouo-Bandjoun (West Cameroon) 
 
The prevalence rates and their confidence intervals (CI) are given in Tables 3 and 4 





Level of education   
 Primary (56)   
 Secondary (68) 0.44 (0.20 - 0.97) 0.04 * 
 Higher (76) 0.62 (0.29 - 1.32) 0.22 
Close contact with cats   
 Never (96)   
 Rarely (39) 1.41 (0.62 - 3.19) 0.41 
 Often (65) 3.00 (1.50 - 6.14) 0.002 ** 
HIV infection   
 No (164)   




The present study shows significant 
difference between the overall sero- 
prevalence of Toxoplasma infection 
among the HIV-positive group (77.7%) 
and HIV-negative patients (36.5%). The 
high seroprevalence of 77.5% in the 
HIV–infected group in our study is in the 
range of 69.9% reported by Assob et al., 
(8) among 133 HIV-positive patients in 
Yaoundé and 77.7% reported by Wam et 




al., (11) among 90 HIV-positive women 
in  Njinikom, north-western Cameroon. 
However, these high Toxoplasma sero- 
prevalence rates are not universal 
because the prevalence rate was only 
27.8% among 72 HIV-positive women in 
Abuja, Nigeria (15).  
The prevalence of 36.5% among 
HIV-negative women in our study 
however contrasts sharply the rates 
reported by other researchers in 
Cameroon. The prevalence rate of 70% 
(77 of 110 pregnant women) was 
reported in Douala (9), 71.8% (122 of 
171) in the Limbe health district (10), 
73.9% (54 of 73) in Njinikom (11) and 
78.6% (257 of 327) by another study in 
Douala (12). Prevalence rates below 
50% have also been reported for HIV-
negative pregnant women in other 
African countries such as Nigeria with 
44.5% (32 of 72) in Abuja (15), 29.9% 
(83 of 276) in Lagos (17), 48.9% (176 of 
360) in Maiduguri (18), as well as 31.1% 
(98 of 316) in Bobo-Dioulasso (16). 
 Although T. gondii is an opport-
unistic pathogen that more readily 
develops when HIV infection is present 
(3, 19), the difference in the prevalence 
rates in our HIV-positive and HIV-
negative women, and in other studies 
cannot be solely explained by 
immunosuppression induced by HIV 
infection. Other plausible explanation for 
this difference may be related to the 
variation which exists in geographical 
and climatic conditions between different 
countries. High seroprevalence rate is 
associated with warmer and wetter 
climates, conditions that are favourable 
for sporulation of Toxoplasma oocysts 
(20, 21). 
In HIV-positive and HIV-negative 
groups, the women with positive IgG 
antibodies were significantly more than 
those with positive IgM antibodies, while 
those positive for both antibodies were 
fewer. Similar observations have been 
reported by other researchers in sub-
Saharan Africa; Ndassi and Kamga (10) 
and Wam et al., (11) in Cameroon, and 
Nasir et al., in Nigeria (18). Compared 
with rates reported by these authors, the 
prevalence rates in the present study for 
all women, regardless of HIV infection, 
were lower; 29.5% for IgG, 11.1% for 
IgM, and 4% for both. Although this 
difference can be interpreted by relating 
it to the heterogeneity in the 
geographical origin of the women in this 
study, another hypothesis based on a 
current decrease in seroprevalence of 
toxoplasmosis in the population living in 
the West region of Cameroon cannot be 
totally excluded.  
The large proportion of infected 
women with positive IgG antibodies in 
the second and third trimesters of 
pregnancy is surprising. However, these 
results are consistent with the kinetics of 
these antibodies during toxoplasmosis. 
As IgM antibodies were negative in these 
patients, it indicates that the infection 
must have occurred more than six 
months before the date of antibody 
detection (22, 23). The presence of IgM 
without IgG in 24 pregnant women may 
actually mean a recent infection of the 
pregnant women because IgM is the first 
immunoglobulin to be produced against 
any new infection. However, the 
presence of both IgG and IgM in 4 HIV-
positive and 4 HIV-negative women is 
more difficult to explain though it may 
indicate either an evolving infection or 
re-infection or re-activation of an old 
infection or changing from acute to 
chronic stage or antibody switching 
occurring at molecular level. A similar 
rate (10.8%) has already been noted by 
Assob et al., (8) among 93 HIV-positive 
women in Cameroon and these authors 
explained this result by the fact that 
most toxoplasma cases in these women 
would probably be due to the 
reactivation of a latent infection. In 
contrast, the occurrence of such rates in 
HIV-negative women has not yet been 
satisfactorily explained.  
The review of literature shows the 
existence of variability in the risk factors 
associated with toxoplasmosis. The 
nature of these varies according to the 
country and the place where each study 
was conducted (6). In the present study, 
the frequent contact with cats was 
significantly associated with the 
prevalence of toxoplasmosis. This finding 
is consistent with the report by 
Nissapatorn et al., (24) in Malaysia but 
disagrees with reports of three others; 
Wam et al., in Cameroon (11), Uttah et 
al., in Nigeria (15) and Agmas et al., in 
Ethiopia (25), as these researchers did 




not find any significant association 
between contact with cats and the 
disease.  
On the other hand, rare contact or 
mere ownership of cats did not show    
any significant relationship with the 
prevalence of the disease in the our 
study, whereas several authors such as 
Njunda et al., (9), Nasir et al., (17) and 
Wam et al., (11) in Cameroon reported a 
significantly higher prevalence of toxo- 
plasmosis in cat owners. This variability 
was also noted in European studies as 
Hofhuis et al., (26) in the Netherlands 
reported an increased risk of toxo-
plasmosis for cat owners, while Petersen 
et al., (27) did not observe such 
association. To explain the difference 
between our results and those of these 
authors, the frequency of close contact 
with this mammal, especially when 
raised as a pet, is probably the main 
cause. The other risk factors analyzed in 
this study did not show significant 
association with the prevalence of the 
disease, and this may be related to the 
women population in our study.  
In conclusion, the seroprevalence of 
T. gondii infection among pregnant 
women population at the Protestant 
Hospital of Mbouo-Bandjoun, Cameroon 
was 45.0% with more infected women in 
the HIV-positive group than in HIV-
negative women. The frequency of close 
contact with cats was significantly 
associated with the prevalence of the 
disease. Compared with previous reports 
of human toxoplasmosis in Cameroon, 
our study reported a decrease in the 
prevalence of the disease. Further 
studies are needed to determine whether 
this decrease is localized to our study or 
a general phenomenon that currently 
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